Commitment COM-288
Post-approval commitment for MHRA-2022-0088. Category: Paediatric Study. Priority: medium.
Commitment ID
COM-288
Application
Authority
Medicines and Healthcare products Regulatory Agency
Category
Paediatric Study
Priority
medium
Status
Overdue
Due Date
2025-07-31
Completed At
—
Owner
Carlos Mendez
Created
2023-08-15
Description
Provide confirmatory bioequivalence study for 200 mg strength
Evidence (0)
No evidence documents attached. Upload evidence to mark this commitment as complete.